End of First: VGK 1, Rangers 0 19:41 VGK Goal: Jack Eichel lands the first goal with an assist from Mark Stone and Pavel Dorofeyev. The Knights have seen more losses than wins these past few weeks ...
0:53 - VGK goal called back: A would-be Ivan Barbashev goal is wiped out after a review showed Vegas was guilty of offsides on the score 1:54 - VGK goal: Knights bounce right back from the non ...
In a report released yesterday, Kostas Biliouris from BMO Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $200.00. Kostas Biliouris has ...
Sarep­ta Ther­a­peu­tics un­veiled new re­sults from the sec­ond part of a clin­i­cal tri­al for its Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py Ele­v­idys … ...
Sarepta (SRPT) announced topline results from Part 2 of EMBARK, a global, randomized, double-blind, placebo-controlled, Phase 3 clinical study of Elevidys, the only approved gene therapy in ...
End of game: Golden Knights struggle to score late in loss to Stars The Vegas Golden Knights had multiple opportunities to tie their game against the Stars late in the third period but were ...
The VGK ETF's recent price increase is driven by strong Q4 earnings expectations for European financial stocks, not by reduced fears of Trump tariffs. Europe faces a complex economic landscape ...